Major Novartis shareholder calls for board shake-up after trial setbacks on September 11, 2026 acquisitions activism Artisan Partners board shake-up compensation reform David Samra Experimental drug Management procedure Novartis setbacks shareholder +
FDA Proposes Streamlined Requirements for Hub‑and‑Spoke Drug Manufacturing Models on July 14, 2026 Distribution drug establishment registration foreign drug manufacturing Management procedure manufacturing United States Food and Drug Administration +
Recent developments in transforming oversight and risk management in pharma R&D on May 14, 2026 Administration occupational activities E6(R3 governance Infectious Canine Hepatitis Management procedure Pharma R&D Risk Management risk-based United States Food and Drug Administration +